Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

Affiliations

• ¹ RM Gorbacheva Research Institute, Pavlov University, Lva Tolstogo St. 6/8, Saint Petersburg, Russian Federation. moisiv@mail.ru.
• ² EBMT Paris Study Office; Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.
• ³ Department of Hematology, Oncology and Internal Medicine, University Clinical Center of the Medical University of Warsaw, Warsaw, Poland.
• ⁴ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany.
• ⁵ Department of Hematology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
• ⁶ Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, Leuven, Belgium.
• ⁷ Department of Hematology, Oncology and Tumorimmunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
• ⁸ School of Medicine, University of Zagreb, Zagreb, Croatia.
• ⁹ University Hospital Centre Zagreb, Zagreb, Croatia.